Skip to main content
. 2019 Aug 5;14(8):e0220685. doi: 10.1371/journal.pone.0220685

Table 2. Frequencies of potential D-interactions with risk of toxicity, categorized according to potential clinical effect.

Potential adverse effect Frequency
Serotonin toxicity and/or anticholinergic side effects 87
SSRI—SSRIa 84
Other (frequency <5) 3
Cardiac arrhythmias 27
Potassium—spironolactone/amiloride 19
Verapamil/diltiazem—beta blockerb 6
Other (frequency <5) 2
Bleeding 24
Warfarin—ASA low dose 14
Warfarin—metronidazole/sulfamethoxazole 6
Other (frequency <5) 4
Sedation 9
Opioidc - phenobarbital 5
Other (frequency <5) 4
Immunosuppressant toxicity 7
Tacrolimus—itraconazole/posaconazole 5
Other (frequency <5) 2
Other adverse effect (frequency < 5) 13
Total adverse effect 167

Potential clinical effects and summarized frequencies in bold. For each group interaction pairs with a frequency <5 are summarized as other. Groups of potential interactions with a frequency <5 are summarized as other. SSRI selective serotonin reuptake inhibitor, ASA acetylsalicylic acid.

a Sertraline, fluoxetine, paroxetine, escitalopram, citalopram.

b Metoprolol, propranolol, bisoprolol.

c Oxycodone, morphine, codeine.